Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04508504 · ClinicalTrials.gov registry record · NA

PENG Block for Arthroscopic Hip Surgery

A NA study of Postoperative Pain and Hip Arthroscopy, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT04508504 is a NA study of Postoperative Pain and Hip Arthroscopy that has completed, run by University of Virginia. The registered enrollment target is 70 participants, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04508504, a NA study of Postoperative Pain and Hip Arthroscopy, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

This randomized, double-blinded, placebo-controlled trial seeks to evaluate the analgesic efficacy of the pericapsular nerve group block in the setting of outpatient hip arthroscopy.

Interventions

  • DRUG Ropivacaine 0.5% Injectable Solution
  • DRUG Normal Saline
  • PROCEDURE Preop PENG block
  • PROCEDURE Placebo block

Study Locations (1)

Virginia

  • UVA Outpatient Surgery Center - Charlottesville

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2020-12-01
Est. Completion 2022-02-08
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT04508504

The ClinicalTrials.gov registry entry for NCT04508504 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (70% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 4 interventions - of which Ropivacaine 0.5% Injectable Solution is the first listed.

NCT04508504 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT04508504 about?

NCT04508504 is a clinical study titled "PENG Block for Arthroscopic Hip Surgery". This randomized, double-blinded, placebo-controlled trial seeks to evaluate the analgesic efficacy of the pericapsular nerve group block in the setting of outpatient hip arthroscopy.

What is the current status of trial NCT04508504?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2020-12-01. Estimated completion is 2022-02-08.

What conditions does trial NCT04508504 study?

This clinical trial studies the following conditions: Postoperative Pain, Hip Arthroscopy.

What interventions are being tested in trial NCT04508504?

The interventions under investigation include: Ropivacaine 0.5% Injectable Solution (DRUG), Normal Saline (DRUG), Preop PENG block (PROCEDURE), Placebo block (PROCEDURE).

Who is sponsoring clinical trial NCT04508504?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04508504 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.